Marshall Wace North America’s ResMed RMD Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2021
Q3 | $2.27M | Buy |
+8,603
| New | +$2.27M | 0.01% | 689 |
|
2021
Q2 | – | Sell |
-301,038
| Closed | -$58.4M | – | 1661 |
|
2021
Q1 | $58.4M | Buy |
301,038
+187,276
| +165% | +$36.3M | 0.24% | 94 |
|
2020
Q4 | $24.2M | Sell |
113,762
-103,221
| -48% | -$21.9M | 0.11% | 211 |
|
2020
Q3 | $37.2M | Buy |
+216,983
| New | +$37.2M | 0.24% | 109 |
|
2020
Q2 | – | Sell |
-170,234
| Closed | -$25.1M | – | 1426 |
|
2020
Q1 | $25.1M | Buy |
+170,234
| New | +$25.1M | 0.19% | 137 |
|
2019
Q3 | – | Sell |
-7,534
| Closed | -$919K | – | 1512 |
|
2019
Q2 | $919K | Buy |
7,534
+4,167
| +124% | +$508K | 0.01% | 777 |
|
2019
Q1 | $350K | Sell |
3,367
-24,446
| -88% | -$2.54M | ﹤0.01% | 870 |
|
2018
Q4 | $3.17M | Buy |
+27,813
| New | +$3.17M | 0.03% | 337 |
|
2018
Q3 | – | Sell |
-15,420
| Closed | -$1.6M | – | 1300 |
|
2018
Q2 | $1.6M | Sell |
15,420
-25,573
| -62% | -$2.65M | 0.01% | 820 |
|
2018
Q1 | $4.04M | Buy |
40,993
+29,154
| +246% | +$2.87M | 0.02% | 616 |
|
2017
Q4 | $1M | Buy |
+11,839
| New | +$1M | 0.01% | 990 |
|
2017
Q2 | – | Sell |
-3,738
| Closed | -$269K | – | 1437 |
|
2017
Q1 | $269K | Buy |
+3,738
| New | +$269K | ﹤0.01% | 880 |
|
2013
Q4 | $22.3M | Buy |
+473,714
| New | +$22.3M | 0.47% | 60 |
|